US buyout fund closes in to pick up around 51-75% in Rosy Blue company; may announce deal soon. People familiar with the situation told ET that Orra has been seeking partners to infuse capital and ...

CORRECTION: An earlier version of this report referred to Advent International as a subsidiary of the Abu Dhabi Investment ...

Advent International, based in Boston, is one of the largest private equity firms with $94 billion in assets and investments across 43 countries. With over 600 employees in 15 offices, Advent ...

Advent International and Permira’s expected acquisition of McAfee would be the third-biggest cybersecurity deal of all-time, behind only Thoma Bravo’s $12.3 billion purchase of Proofpoint and ...

US buyout fund Advent International is eyeing a controlling stake in Rosy Blue-owned Orra Fine Jewellery. This and more in todays ETtech Morning Dispatch.

Amid a larger disruption by new-age brands and lab-grown diamonds, Orra Fine Jewellery, owned by Rosy Blue Group has been ...

BOSTON & RICHMOND, Va.--(BUSINESS WIRE)--Advent International (“Advent”), a leading global private equity investor, today announced that it has signed a definitive agreement to acquire Sauer ...

Private equity firm Advent International has signed an agreement to acquire Sauer Brands, the owner of Duke's Mayo, from Falfurrias Capital Partners. The companies did not disclose the financial ...

New Delhi, Nov 19 () Private equity firm Advent International has signed an agreement to acquire a majority stake in biopharmaceutical firm Bharat Serums and Vaccines. "With this transaction ...

Fintech platform KreditBee on Friday said it has closed $200 million in its Series D round by raising an additional $100 million in primary funding from Advent International, Mitsubishi UFJ ...

Moneycontrol was the first to report the firm's sale plans on December 2. Advent International is expecting a valuation between $1.5 bn to $2bn for its portfolio company, the report had added.

This comes even as private equity giants Advent International and Carlyle Group made binding offers to buy up to 15% stake in India’s fifth largest pharma company by retail market share.